Johnson & Johnson (JNJ) to Issue Quarterly Dividend of $1.34 on September 8th

Johnson & Johnson (NYSE:JNJ) announced a quarterly dividend on Wednesday, July 15th. Shareholders of record on Tuesday, August 25th will be given a dividend of 1.34 per share on Tuesday, September 8th. This represents a c) dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend is Tuesday, August 25th.

Johnson & Johnson has raised its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend every year for the last 64 years. Johnson & Johnson has a dividend payout ratio of 48.3% meaning its dividend is sufficiently covered by earnings. Research analysts expect Johnson & Johnson to earn $12.80 per share next year, which means the company should continue to be able to cover its $5.36 annual dividend with an expected future payout ratio of 41.9%.

Johnson & Johnson Stock Up 1.2%

NYSE JNJ opened at $270.69 on Friday. The company has a current ratio of 1.09, a quick ratio of 0.81 and a debt-to-equity ratio of 0.44. The company has a market cap of $652.34 billion, a price-to-earnings ratio of 31.37, a PEG ratio of 2.58 and a beta of 0.24. The company has a 50 day moving average of $255.08 and a 200-day moving average of $242.72. Johnson & Johnson has a 1-year low of $173.33 and a 1-year high of $276.47.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings results on Wednesday, July 15th. The company reported $2.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.84 by $0.06. The business had revenue of $25.31 billion for the quarter, compared to the consensus estimate of $25.06 billion. Johnson & Johnson had a return on equity of 32.42% and a net margin of 21.48%.The firm’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.77 earnings per share. Johnson & Johnson has set its FY 2026 guidance at 11.600-11.750 EPS. On average, equities research analysts expect that Johnson & Johnson will post 11.61 earnings per share for the current fiscal year.

Johnson & Johnson Company Profile

Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.

The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.